Published in J Obstet Gynaecol Br Commonw on July 01, 1972
Plasma oxytocin during third stage of labour: comparison of natural and active management. BMJ (1988) 1.00
How effective are the components of active management of the third stage of labor? BMC Pregnancy Childbirth (2013) 0.94
Misoprostol to reduce intraoperative and postoperative hemorrhage during cesarean delivery: a systematic review and metaanalysis. Am J Obstet Gynecol (2013) 0.80
Umbilical cord clamping in preterm infants. BMJ (1993) 0.75
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol (1999) 3.56
Health education for pregnant smokers: its behavioral impact and cost benefit. Am J Public Health (1993) 2.44
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychol (1998) 2.18
Placental lactogen levels as a screening test for fetal distress and neonatal asphyxia. Lancet (1972) 1.85
The Kaiser Permanente prenatal smoking-cessation trial: when more isn't better, what is enough? Am J Prev Med (1999) 1.74
Microcomputers in antenatal care: a feasibility study on the booking interview. Br Med J (Clin Res Ed) (1981) 1.70
Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav (1998) 1.68
Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Lancet (1975) 1.67
Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychol (1997) 1.62
Point-of-purchase messages framed in terms of cost, convenience, taste, and energy improve healthful snack selection in a college foodservice setting. J Am Diet Assoc (2001) 1.60
A rapid radioimmunoassay for human chorionic somatomammotrophin. J Obstet Gynaecol Br Commonw (1971) 1.54
A meta-evaluation of smoking cessation intervention research among pregnant women: improving the science and art. Health Educ Res (1998) 1.53
Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Mol Psychiatry (2000) 1.44
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine. J Endocrinol (1972) 1.43
Early amniocentesis: alphafetoprotein levels in amniotic fluid, extraembryonic coelomic fluid and maternal serum between 8 and 13 weeks. Br J Obstet Gynaecol (1991) 1.42
Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev (1998) 1.41
Lack of evidence for a circadian rhythm of IGFBP-1 in the mother and fetus during labour. Br J Obstet Gynaecol (1995) 1.41
A self-help intervention for African American smokers: tailoring cancer information service counseling for a special population. Prev Med (1998) 1.39
Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies. Prenat Diagn (1995) 1.39
Simplified method for measuring sex-hormone binding globulin. Clin Chem (1981) 1.35
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Specific and sensitive determination of pregnancy-specific beta 1-glycoprotein by radioimmunoassay. A new pregnancy test. Lancet (1977) 1.31
A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight. J Obstet Gynaecol Br Commonw (1971) 1.30
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
Placental lactogen levels as guide to outcome of threatened abortion. Br Med J (1972) 1.24
Strengths and weaknesses of direct patient interviewing by a microcomputer system in specialist gynaecological practice. Eur J Obstet Gynecol Reprod Biol (1984) 1.20
The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer (1996) 1.19
The development of on-line history-taking systems in antenatal care. Methods Inf Med (1983) 1.18
Concentrations of pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet (1977) 1.17
Audit of compliance with antenatal protocols. BMJ (1992) 1.13
Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Dipstick method for human chorionic gonadotropin suitable for emergency use on whole blood and other fluids. Lancet (1985) 1.09
Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin Obstet Gynaecol (1991) 1.09
alpha-Fetoprotein levels in pregnancies complicated by gastrointestinal abnormalities of the fetus. Br J Obstet Gynaecol (1977) 1.09
In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br J Cancer (1987) 1.08
Release of oxytocin and vasopressin by the human foetus during labour. Nature (1971) 1.07
Oxytocin release by infused prostaglandin. Br Med J (1972) 1.06
Use of a rapid hCG-beta-subunit radioimmunoassay in acute gynaecological emergencies. Lancet (1980) 1.05
Use of a microcomputer network for history taking in a prenatal clinic. Am J Perinatol (1985) 1.05
Circulating levels of pregnancy-specific beta1-glycoprotein in early pregnancy. Br J Obstet Gynaecol (1977) 1.03
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer (1980) 1.03
A retrospective comparison of water births and conventional vaginal deliveries. Eur J Obstet Gynecol Reprod Biol (2000) 1.02
The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancy. Clin Chim Acta (1979) 1.02
Human foetal pituitary peptides and parturition. Nature (1976) 1.02
The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev (1998) 1.01
Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol (1989) 1.00
Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet (1973) 1.00
Urinary multiple marker screening for Down's syndrome. Prenat Diagn (1995) 0.99
New bioassay for luteinizing hormone. Nature (1973) 0.99
Urinary beta-core human chorionic gonadotrophin: a new approach to Down's syndrome screening. Prenat Diagn (1994) 0.97
Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older. Br J Obstet Gynaecol (1995) 0.97
The fetus at risk. Lancet (1974) 0.97
Problems and pitfalls of risk assessment in antenatal care. Br J Obstet Gynaecol (1983) 0.97
Possible placental origin of ACTH in normal human pregnancy. Nature (1975) 0.96
Self-learning for a Bayesian knowledge base: how long does it take for the machine to educate itself? Methods Inf Med (1987) 0.96
The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution. J Endocrinol (1972) 0.96
The use of significant reduction rates to evaluate health education methods for pregnant smokers: a new harm reduction behavioral indicator? Health Educ Behav (1999) 0.95
Placental protein 12 (PP12): a new test for the prediction of the small-for-gestational-age infant. Br J Obstet Gynaecol (1985) 0.95
Circulating levels of relaxin are normal in pregnant women with pelvic pain. Eur J Obstet Gynecol Reprod Biol (1997) 0.95
Serum fibrin(ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery. Lancet (1975) 0.95
Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol (1993) 0.94
The development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol (1975) 0.94
A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females. Gynecol Endocrinol (1987) 0.94
Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration. Am J Obstet Gynecol (1976) 0.94
Doubts about human chorionic gonadotropin as a thyroid stimulator. Lancet (1985) 0.94
Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther (1988) 0.93
Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) (1974) 0.93
Immunological enhancement by mouse isoantibodies: the importance of complement fixation. Immunology (1968) 0.93
Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br J Cancer (1990) 0.93
Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer (2000) 0.92
Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer. Br J Urol (1987) 0.92
Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy. Lancet (1973) 0.92
Immunochemical analysis of the human chorionic gonadotrophin-like material secreted by 'normal' and neoplastic urothelial cells. J Mol Endocrinol (1989) 0.92
Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol (1991) 0.92
The radioimmunoassay of oxytocin and vasopressin. J Endocrinol (1973) 0.92
Development of a radioimmunoassay for adrenal specific protein: its measurement in biological fluids and tissues. J Endocrinol (1979) 0.91
Identification and purification of a new protein from water-soluble extracts of human adrenal gland. J Endocrinol (1979) 0.91
Reproducibility of measurement of fetal biparietal diameter by ultrasonic cephalometry. J Obstet Gynaecol Br Commonw (1974) 0.91
Placental lactogen levels in diabetic pregnancy. Br Med J (1973) 0.91
Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol (1996) 0.91
Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. Br J Urol (1996) 0.91
A national survey to assess current use of computerised information systems in obstetrics. Br J Obstet Gynaecol (1993) 0.91
Immunoreactive human chorionic gonadotrophin from the cyst fluid and CSF of patients with craniopharyngioma. Clin Endocrinol (Oxf) (1988) 0.91
Steroid hormone abnormalities in women with severe idiopathic constipation. Gut (1991) 0.90
The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J Endocrinol (1991) 0.90
Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab (1997) 0.90
Evaluation of an antenatal HIV testing programme in an inner London health district. Br J Obstet Gynaecol (1994) 0.90
Risk factors for HIV infection overlooked in routine antenatal care. J R Soc Med (1995) 0.90
Circulating levels of fibrin/fibrinogen degradation fragment E measured by radioimmunoassay in pre-eclampsia. Br J Obstet Gynaecol (1976) 0.89
The routine use of ultrasound. Br J Obstet Gynaecol (1985) 0.89
The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol (1991) 0.89
May spina bifida result from an X-linked defect in a selective abortion mechanism? J Med Genet (1979) 0.88